Clinical Trial Update: Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating valproic acid (Depakine) in progressive supranuclear palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• Valproic Acid (Depakine) (valproic acid)

Snippet

Sponsor: Nantes University Hospital | Conditions: Progressive Supranuclear Palsy | Phase 2 | Status: COMPLETED